Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul G Hynes

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Carcinogenesis|April 25, 2012
Prostate cancer stem cells: The case for model systemsPaul G Hynes, Kathleen Kelly
Hypertension in Pregnancy|May 20, 2008
Beta-adrenoceptor subtype expression in human placenta and umbilical arteries in normal and preeclamptic pregnanciesPaul G Hynes, Anne M Friel, Terry J Smith, et al.
Stem Cells (Dayton, Ohio)|October 12, 2010
Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten-/-TP53-/- prostate cancer modelWassim G Abou-Kheir, Paul G Hynes, Philip L Martin, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|December 20, 2007
Expression levels of mRNA for Rho A/Rho kinase and its role in isoprostane-induced vasoconstriction of human placental and maternal vesselsAnne M Friel, Paul G Hynes, Donal J Sexton, et al.
Plos One|October 25, 2011
Self-renewing Pten-/- TP53-/- protospheres produce metastatic adenocarcinoma cell lines with multipotent progenitor activityWassim Abou-Kheir, Paul G Hynes, Philip Martin, et al.
Molecular and Cellular Biology|March 25, 2015
Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone MetastasisYen-Nien Liu, JuanJuan Yin, Ben Barrett, et al.
Plos One|August 4, 2012
TMPRSS2- driven ERG expression in vivo increases self-renewal and maintains expression in a castration resistant subpopulationOrla M Casey, Lei Fang, Paul G Hynes, et al.
Cell Reports|December 3, 2015
Identification of Different Classes of Luminal Progenitor Cells within Prostate TumorsSupreet Agarwal, Paul G Hynes, Heather S Tillman, et al.
Scientific Reports|November 24, 2018
High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancerKeith H Jansson, John B Tucker, Lauren E Stahl, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Carcinogenesis|April 25, 2012
Prostate cancer stem cells: The case for model systemsPaul G Hynes, Kathleen Kelly
Hypertension in Pregnancy|May 20, 2008
Beta-adrenoceptor subtype expression in human placenta and umbilical arteries in normal and preeclamptic pregnanciesPaul G Hynes, Anne M Friel, Terry J Smith, et al.
Stem Cells (Dayton, Ohio)|October 12, 2010
Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten-/-TP53-/- prostate cancer modelWassim G Abou-Kheir, Paul G Hynes, Philip L Martin, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|December 20, 2007
Expression levels of mRNA for Rho A/Rho kinase and its role in isoprostane-induced vasoconstriction of human placental and maternal vesselsAnne M Friel, Paul G Hynes, Donal J Sexton, et al.
Plos One|October 25, 2011
Self-renewing Pten-/- TP53-/- protospheres produce metastatic adenocarcinoma cell lines with multipotent progenitor activityWassim Abou-Kheir, Paul G Hynes, Philip Martin, et al.
Molecular and Cellular Biology|March 25, 2015
Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone MetastasisYen-Nien Liu, JuanJuan Yin, Ben Barrett, et al.
Plos One|August 4, 2012
TMPRSS2- driven ERG expression in vivo increases self-renewal and maintains expression in a castration resistant subpopulationOrla M Casey, Lei Fang, Paul G Hynes, et al.
Cell Reports|December 3, 2015
Identification of Different Classes of Luminal Progenitor Cells within Prostate TumorsSupreet Agarwal, Paul G Hynes, Heather S Tillman, et al.
Scientific Reports|November 24, 2018
High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancerKeith H Jansson, John B Tucker, Lauren E Stahl, et al.
Pageof 1